Trial Profile
Safety and Efficacy of Peri-procedural Use of Tirofiban in Elective Percutaneous Coronary Intervention for Long Coronary Lesions With Overlapping Drug-Eluting Stent
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms PETITION
- 29 Dec 2011 New trial record